Lee:JC - Revision history

Wooin Lee: /* Suggested future papers */

2013-05-17T13:50:37Z

Suggested future papers

←Older revision		Revision as of 13:50, 17 May 2013
Line 53:		Line 53:

	==Suggested future papers==		==Suggested future papers==
-	# Eloranta JJ, Hiller C, Juttner M, Kullak-Ublick GA. The SLCO1A2 Gene, Encoding the Human Organic Anion Transporting Polypeptide 1A2 (OATP1A2), is Transactivated by the Vitamin D Receptor (VDR). Mol Pharmacol. 2012 Apr 3. [Epub ahead of print]
-	# Roué G, Pérez-Galán P, Mozos A, López-Guerra M, Xargay-Torrent S, Rosich L, Saborit-Villarroya I, Normant E, Campo E, Colomer D. The Hsp90 inhibitor IPI-504 overcomes bortezomib resistance in mantle cell lymphoma in vitro and in vivo by down-regulation of the prosurvival ER chaperone BiP/Grp78. Blood. 2011 Jan 27;117(4):1270-9. Epub 2010 Nov 24.
	# Whitman SP, Hackanson B, Liyanarachchi S, Liu S, Rush LJ, Maharry K, Margeson D, Davuluri R, Wen J, Witte T, Yu L, Liu C, Bloomfield CD, Marcucci G, Plass C, Caligiuri MA. DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication. Blood. 2008 Sep 1;112(5):2013-6. pmid=18566324		# Whitman SP, Hackanson B, Liyanarachchi S, Liu S, Rush LJ, Maharry K, Margeson D, Davuluri R, Wen J, Witte T, Yu L, Liu C, Bloomfield CD, Marcucci G, Plass C, Caligiuri MA. DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication. Blood. 2008 Sep 1;112(5):2013-6. pmid=18566324
	# Kotamraju S, Matalon S, Matsunaga T, Shang T, Hickman-Davis JM, Kalyanaraman B. Upregulation of immunoproteasomes by nitric oxide: potential antioxidative mechanism in endothelial cells. Free Radic Biol Med. 2006 Mar 15;40(6):1034-44. pmid=16540399		# Kotamraju S, Matalon S, Matsunaga T, Shang T, Hickman-Davis JM, Kalyanaraman B. Upregulation of immunoproteasomes by nitric oxide: potential antioxidative mechanism in endothelial cells. Free Radic Biol Med. 2006 Mar 15;40(6):1034-44. pmid=16540399

Wooin Lee: /* 2013 */

2013-05-17T13:49:44Z

2013

←Older revision		Revision as of 13:49, 17 May 2013
Line 71:		Line 71:
	# Ali BR, Xu H, Akawi NA, John A, Karuvantevida NS, Langer R, Al-Gazali L, Leitinger B. Trafficking defects and loss of ligand binding are the underlying causes of all reported DDR2 missense mutations found in SMED-SL patients.Hum Mol Genet. 2010 Jun 1;19(11):2239-50. doi: 10.1093/hmg/ddq103. Epub 2010 Mar 10. (3/18/13, YRL)		# Ali BR, Xu H, Akawi NA, John A, Karuvantevida NS, Langer R, Al-Gazali L, Leitinger B. Trafficking defects and loss of ligand binding are the underlying causes of all reported DDR2 missense mutations found in SMED-SL patients.Hum Mol Genet. 2010 Jun 1;19(11):2239-50. doi: 10.1093/hmg/ddq103. Epub 2010 Mar 10. (3/18/13, YRL)
	# Knauer MJ, Girdwood AJ, Kim RB, Tirona RG. Transport Function and Transcriptional Regulation of a Liver-Enriched Human Organic Anion Transporting Polypeptide 2B1 Transcriptional Start Site Variant. Mol Pharmacol. 2013 Mar 26 (4/15/13, NT)		# Knauer MJ, Girdwood AJ, Kim RB, Tirona RG. Transport Function and Transcriptional Regulation of a Liver-Enriched Human Organic Anion Transporting Polypeptide 2B1 Transcriptional Start Site Variant. Mol Pharmacol. 2013 Mar 26 (4/15/13, NT)
		+	# Roué G, Pérez-Galán P, Mozos A, López-Guerra M, Xargay-Torrent S, Rosich L, Saborit-Villarroya I, Normant E, Campo E, Colomer D. The Hsp90 inhibitor IPI-504 overcomes bortezomib resistance in mantle cell lymphoma in vitro and in vivo by down-regulation of the prosurvival ER chaperone BiP/Grp78. Blood. 2011 Jan 27;117(4):1270-9. doi: 10.1182/blood-2010-04-278853. Epub 2010 Nov 24. (4/29/13, LA)
		+	# Zhang K, Corsa CA, Ponik SM, Prior JL, Piwnica-Worms D, Eliceiri KW, Keely PJ, Longmore GD. The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis.Nat Cell Biol. 2013 May 5. doi: 10.1038/ncb2743. (5/13/13, W)

	===2012===		===2012===

Wooin Lee: /* Lee Lab JC */

2013-04-16T13:01:41Z

Lee Lab JC

←Older revision		Revision as of 13:01, 16 April 2013
Line 14:		Line 14:
	\|width='200'\|'''Presenter'''		\|width='200'\|'''Presenter'''
	\|-		\|-
-	\|4/1/13 \|\| ~~Youngran~~	+	\|4/29/13 \|\| Lin
	\|-		\|-
-	\|4/15/13 \|\| ~~Nilay~~	+	\|5/13/13 \|\| W
	\|-		\|-
-	\|4/29/13 \|\| Lin	+	\|5/27/13 \|\| no JC (Memorial day)
		+	\|-
		+	\|6/10/13 \|\| Youngran
		+	\|-
		+	\|6/24/13 \|\| Nilay
		+	\|-
		+	\|7/8/13 \|\| Christian
		+	\|-
		+	\|7/22/13 \|\| Lin
	\|-		\|-
-	\|5/13~~/13~~ \|\| ~~Nilay~~	+	\|8/5/13 \|\| W
	\|-		\|-
	\|}		\|}

Wooin Lee: /* 2013 */

2013-04-15T18:47:29Z

2013

←Older revision		Revision as of 18:47, 15 April 2013
Line 61:		Line 61:
	# Ramachandran A, Betts G, Bhana S, Helme G, Blick C, Moller-Levet C, Saunders E, Valentine H, Pepper S, Miller CJ, Buffa F, Harris AL, West CM. An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3. Eur J Cancer. 2013 Jan 23. doi:pii: S0959-8049(12)00960-4. 10.1016/j.ejca.2012.12.003 (2/18/13, KBK)		# Ramachandran A, Betts G, Bhana S, Helme G, Blick C, Moller-Levet C, Saunders E, Valentine H, Pepper S, Miller CJ, Buffa F, Harris AL, West CM. An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3. Eur J Cancer. 2013 Jan 23. doi:pii: S0959-8049(12)00960-4. 10.1016/j.ejca.2012.12.003 (2/18/13, KBK)
	# Maldonado M, Kapphahn RJ, MR Terluk, ND Heuss, C Yuan, DS Gregerson, DA Ferrington. Immunoproteasome Deficiency Modifies the Alternative Pathway of NFκB Signaling. Plos One 2013 (3/4/13, LA)		# Maldonado M, Kapphahn RJ, MR Terluk, ND Heuss, C Yuan, DS Gregerson, DA Ferrington. Immunoproteasome Deficiency Modifies the Alternative Pathway of NFκB Signaling. Plos One 2013 (3/4/13, LA)
		+	# Ali BR, Xu H, Akawi NA, John A, Karuvantevida NS, Langer R, Al-Gazali L, Leitinger B. Trafficking defects and loss of ligand binding are the underlying causes of all reported DDR2 missense mutations found in SMED-SL patients.Hum Mol Genet. 2010 Jun 1;19(11):2239-50. doi: 10.1093/hmg/ddq103. Epub 2010 Mar 10. (3/18/13, YRL)
		+	# Knauer MJ, Girdwood AJ, Kim RB, Tirona RG. Transport Function and Transcriptional Regulation of a Liver-Enriched Human Organic Anion Transporting Polypeptide 2B1 Transcriptional Start Site Variant. Mol Pharmacol. 2013 Mar 26 (4/15/13, NT)

	===2012===		===2012===

Wooin Lee: /* Lee Lab JC */

2013-03-19T16:21:22Z

Lee Lab JC

←Older revision		Revision as of 16:21, 19 March 2013
Line 13:		Line 13:
	\|width='200'\|'''Date'''		\|width='200'\|'''Date'''
	\|width='200'\|'''Presenter'''		\|width='200'\|'''Presenter'''
-	\|-
-	~~\|2/4/13 \|\| Youngran~~
-	\|-
-	~~\|2/18/13 \|\| KB~~
-	\|-
-	~~\|3/4/13 \|\| Lin~~
-	\|-
-	~~\|3/18/13 \|\| Nilay~~
	\|-		\|-
	\|4/1/13 \|\| Youngran		\|4/1/13 \|\| Youngran
	\|-		\|-
-	\|4/15/13 \|\| W	+	\|4/15/13 \|\| Nilay
	\|-		\|-
	\|4/29/13 \|\| Lin		\|4/29/13 \|\| Lin

Wooin Lee: /* Lee Lab JC */

2013-03-04T20:07:17Z

Lee Lab JC

←Older revision		Revision as of 20:07, 4 March 2013
Line 24:		Line 24:
	\|4/1/13 \|\| Youngran		\|4/1/13 \|\| Youngran
	\|-		\|-
-	\|4/15/13 \|\| KB	+	\|4/15/13 \|\| W
	\|-		\|-
	\|4/29/13 \|\| Lin		\|4/29/13 \|\| Lin

Wooin Lee: /* 2013 */

2013-03-04T20:06:30Z

2013

←Older revision		Revision as of 20:06, 4 March 2013
Line 68:		Line 68:
	# Day E, Waters B, Spiegel K, Alnadaf T, Manley PW, Buchdunger E, Walker C, Jarai G. Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib.Eur J Pharmacol. 2008 Dec 3;599(1-3):44-53 (2/4/13 YRL)		# Day E, Waters B, Spiegel K, Alnadaf T, Manley PW, Buchdunger E, Walker C, Jarai G. Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib.Eur J Pharmacol. 2008 Dec 3;599(1-3):44-53 (2/4/13 YRL)
	# Ramachandran A, Betts G, Bhana S, Helme G, Blick C, Moller-Levet C, Saunders E, Valentine H, Pepper S, Miller CJ, Buffa F, Harris AL, West CM. An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3. Eur J Cancer. 2013 Jan 23. doi:pii: S0959-8049(12)00960-4. 10.1016/j.ejca.2012.12.003 (2/18/13, KBK)		# Ramachandran A, Betts G, Bhana S, Helme G, Blick C, Moller-Levet C, Saunders E, Valentine H, Pepper S, Miller CJ, Buffa F, Harris AL, West CM. An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3. Eur J Cancer. 2013 Jan 23. doi:pii: S0959-8049(12)00960-4. 10.1016/j.ejca.2012.12.003 (2/18/13, KBK)
-	#	+	# Maldonado M, Kapphahn RJ, MR Terluk, ND Heuss, C Yuan, DS Gregerson, DA Ferrington. Immunoproteasome Deficiency Modifies the Alternative Pathway of NFκB Signaling. Plos One 2013 (3/4/13, LA)

	===2012===		===2012===

Wooin Lee: /* 2013 */

2013-03-04T20:04:27Z

2013

←Older revision		Revision as of 20:04, 4 March 2013
Line 67:		Line 67:
	# Pinilla-Macua I, Casado FJ, Pastor-Anglada M. Structural determinants for rCNT2 sorting to the plasma membrane of polarized and non-polarized cells. Biochem J. 2012 Mar 15;442(3):517-25. doi: 10.1042/BJ20110605. (1/7/13 NT)		# Pinilla-Macua I, Casado FJ, Pastor-Anglada M. Structural determinants for rCNT2 sorting to the plasma membrane of polarized and non-polarized cells. Biochem J. 2012 Mar 15;442(3):517-25. doi: 10.1042/BJ20110605. (1/7/13 NT)
	# Day E, Waters B, Spiegel K, Alnadaf T, Manley PW, Buchdunger E, Walker C, Jarai G. Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib.Eur J Pharmacol. 2008 Dec 3;599(1-3):44-53 (2/4/13 YRL)		# Day E, Waters B, Spiegel K, Alnadaf T, Manley PW, Buchdunger E, Walker C, Jarai G. Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib.Eur J Pharmacol. 2008 Dec 3;599(1-3):44-53 (2/4/13 YRL)
		+	# Ramachandran A, Betts G, Bhana S, Helme G, Blick C, Moller-Levet C, Saunders E, Valentine H, Pepper S, Miller CJ, Buffa F, Harris AL, West CM. An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3. Eur J Cancer. 2013 Jan 23. doi:pii: S0959-8049(12)00960-4. 10.1016/j.ejca.2012.12.003 (2/18/13, KBK)
		+	#

	===2012===		===2012===

Wooin Lee: /* 2013 */

2013-02-05T15:09:26Z

2013

←Older revision		Revision as of 15:09, 5 February 2013
Line 66:		Line 66:
	===2013===		===2013===
	# Pinilla-Macua I, Casado FJ, Pastor-Anglada M. Structural determinants for rCNT2 sorting to the plasma membrane of polarized and non-polarized cells. Biochem J. 2012 Mar 15;442(3):517-25. doi: 10.1042/BJ20110605. (1/7/13 NT)		# Pinilla-Macua I, Casado FJ, Pastor-Anglada M. Structural determinants for rCNT2 sorting to the plasma membrane of polarized and non-polarized cells. Biochem J. 2012 Mar 15;442(3):517-25. doi: 10.1042/BJ20110605. (1/7/13 NT)
		+	# Day E, Waters B, Spiegel K, Alnadaf T, Manley PW, Buchdunger E, Walker C, Jarai G. Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib.Eur J Pharmacol. 2008 Dec 3;599(1-3):44-53 (2/4/13 YRL)

	===2012===		===2012===

Wooin Lee: /* Lee Lab JC */

2013-01-22T20:09:53Z

Lee Lab JC

←Older revision		Revision as of 20:09, 22 January 2013
Line 14:		Line 14:
	\|width='200'\|'''Presenter'''		\|width='200'\|'''Presenter'''
	\|-		\|-
-	\|1/7/13 \|\| ~~Nilay~~	+	\|2/4/13 \|\| Youngran
	\|-		\|-
-	\|1/21/13 \|\| ~~Youngran~~	+	\|2/18/13 \|\| KB
	\|-		\|-
-	\|2/4/13 \|\| KB	+	\|3/4/13 \|\| Lin
	\|-		\|-
-	\|2/18/13 \|\| ~~Lin~~	+	\|3/18/13 \|\| Nilay
	\|-		\|-
-	\|3/4/13 \|\| ~~Nilay~~	+	\|4/1/13 \|\| Youngran
	\|-		\|-
-	\|3/18/13 \|\| ~~Youngran~~	+	\|4/15/13 \|\| KB
	\|-		\|-
-	\|4/1/13 \|\| KB	+	\|4/29/13 \|\| Lin
	\|-		\|-
-	\|~~4/15~~/13 ~~\|\| Lin~~	+	\|5/13/13 \|\| Nilay
-	\|-	+
-	~~\|4/29~~/13 \|\| Nilay	+
-	\|-	+
-	~~\|5/13/13 \|\| Youngran~~	+
-	\|-	+
-	~~\|5/27/13 \|\| KB~~	+
	\|-		\|-
	\|}		\|}